Not soon after China revealed the discovery of SARS-CoV-2 in their country, scientists around the world began acting. This was a different type of coronavirus than had been studied since at least 1980.1

One difference is the gain of function potential capabilities the virus is believed to have2 that have been used in lab settings to alter the function of cells “as powerful tools to understand basic bacterial and viral biology and pathogen-host interactions.”3 The U.S. had banned this research in 2014, but in 2017 it was quietly lifted and4

“… the US National Institutes of Health (NIH) announced that they would resume funding gain-of-function experiments involving influenza, Middle East respiratory syndrome coronavirus, and severe acute respiratory syndrome coronavirus [SARS].”

The novel coronavirus appeared to trigger a wide range of symptoms in people. Some had only a mild affliction; others were sick for weeks and still others suffered such serious respiratory debilitation that they required the assistance of a ventilator.5

Your Blood Type May Reveal Risk Profile

After the SARS outbreak of 2003, researchers found that one specific blood type, Type O, had a potential protective effect against that strain of the coronavirus.6 Scientists have also been looking at what genetic factors may impact infection and its severity for people exposed to SARS-CoV-2.

The home-based genetic testing company 23andMe released preliminary results from a study they conducted using the information of more than 750,000 people.7 Their early results suggest that a person’s blood type has an influence on their susceptibility to the virus.

In addition to the information they used from among the millions who have sent their DNA to the company,8 they want to add data from 10,000 hospitalized patients who are not already part of their database.9

The company reported that the percentage who tested positive for COVID-19 by blood type was 4.1% for blood group AB.10 The differences reported in the study showed that those with type O had a 9% or 18% lower potential for testing positive for the virus when compared to those with blood types A, B or AB.11

In a separate study, researchers found that individuals with blood type O Rh positive had the best protection.12 23andMe did not find any differences between the two RH factors, positive or negative.13 It’s important to note that data were collected from self-reported information, which may reduce the validity of this study.14

In an investigation from China, researchers compared the blood types of 2,173 patients who tested positive for SARS-CoV-2.15 The results demonstrated that those with blood type O had a lower risk of infection and those with blood type A had a higher risk. The results of this study are early, and the researchers warn they should be used only as a guide.

A different group of researchers evaluated the health information of people who had respiratory failure; in addition to reviewing the data from a control group, they studied individuals who were patients at seven hospitals in Italy and Spain.16 In the final analysis, 835 people from Italy and 775 people from Spain who tested positive for the virus were included.

The researchers analyzed 8.5 million single-nucleotide polymorphisms, which are genetic variations.17 They found statistically significant genetic differences in blood groups. They also found a higher risk for individuals who have A-positive blood and a lower risk for those with blood type O.

It’s important to remember that the results do not demonstrate there is absolute protection or risk with blood type, only that those with blood type O may have a lower risk and those with blood type A may have a slightly higher risk. The results from Italy and Spain add to a growing body of evidence indicating that blood type has some impact on a person’s susceptibility to the SARS-CoV-2 infection.18

Laura Cooling from the University of Michigan said that the current data don’t match the epidemiology of the disease pattern in the U.S.19 She pointed out that blood type O is more prevalent in the population of African-Americans, who are experiencing a disproportionately higher number of infections.

This suggests that blood type may be less of a risk factor compared to others, such as comorbidities known to increase the risk of severe conditions and disease such as vitamin D deficiency, obesity, diabetes and cardiovascular diseases.20

What’s Important About Blood Type?

Blood type has an impact on emergency care and transfusion; a successful transfusion requires that the person receiving the blood gets the same type from a donor.

Your blood type is determined by the presence or absence of antigens on the surface of every red blood cell. These give your blood specific characteristics, including blood type. The four major types that are determined by two specific antigens, A and B, include A, B, AB and O. Another factor, Rh, may also be present.

The most common blood types are O-positive and A-positive. The approximate distribution of blood types ranges from type O-positive at 38% of the population to type AB-negative at 1% of the population.21

At this time, it’s not understood how blood type may play a role in susceptibility to COVID-19. Professor Andre Franke from the University of Kiel is an author of the study from Italy and Spain.22 He found the gene to type blood is near a gene that controls a protein for a strong immune response.

The overreaction of the immune system, called a cytokine storm, is primarily what causes a massive inflammatory response and lung damage with COVID-19. Theoretically, this genetic variation may have an influence over the immune system and explain the link to blood type.

Consider These Risks Before Taking a Home DNA Test

The number of people using at-home DNA tests to track their ancestry, confirm their heritage or get information on blood type grew through 2019, as demonstrated by the large population that 23andMe used in their study.23,24

Although saw recent growth, that company, along with, which also collects your DNA, began losing sales in 2019. However, these tests are not risk-free. They still hold the data on everyone who’s sent them information, however.25 The potential use for DNA ranges from mapping your family tree and helping find genetic indicators to identifying health conditions and solving crimes.

The last two are usually done in highly regulated labs, while DNA to identify your family tree is not. The at-home test kit allows you to check your results online.26 In so doing, you have to give the company permission to store your information in their database. This is the same database 23andMe used to perform the recent comparison of blood type and COVID-19 infection.

Information may also be used in other ways, depending on the rules of the company. With some, your use of their services allows them to sell your genetic data to third parties without your consent and without profit sharing. Pharmaceutical companies, as an example, need large DNA data sets to develop new drugs.

These data are typically sold for millions of dollars, but those who provide the data realize none of the profits.27 That irony is compounded by the fact that consumers have to pay about $99 to get their DNA tested, which then becomes freely available for corporate use and profiteering, among other things, over which the donors have no control.

Your DNA is your most personal set of information, which can be used and manipulated in several ways. In an era when companies have difficulty keeping your usernames and passwords safe, it isn’t unrealistic to think your DNA data may also be at risk.

In 2013 researchers published a paper demonstrating that it was possible to identify people participating in genetic research studies by cross-referencing their data with information freely available on the internet.28,29 Scientists are excited about the potential information that may be gleaned from large DNA databases, but it poses a problem for your privacy.

Direct-to-consumer DNA testing companies are not bound by HIPAA regulations, which means your personal health information is not protected.30 Even if there is no leak, your genetic information may be used by employers, life insurance organizations and health insurance companies. In fact, in 2013, 23andMe admitted that the goal of their company was to collect massive amounts of DNA data to use without donors’ consent.31

Steps to Optimize Your Health and Support Your Immune System

It is helpful to know your blood type, but that is likely not a strong factor in your ability to withstand a viral infection. The number of people who are dying from COVID-19 lies somewhere between the World Health Organization’s estimate of 3.4%32 and a study in Nature Medicine indicating 1.4%.33

With many cases going unreported or untested, many of the mild and asymptomatic cases are likely not included in the figures. This means the death rate would be lower. In a study from Italy’s national health authority, 99% of the deaths in Italy were in people who had underlying medical conditions.34

Of those reported, 48.5% had 3 or more comorbidities.35 This points to the importance of addressing any underlying conditions you may have. It’s important that you work to optimize your health in ways that don’t also result in unwanted side effects or conditions related to taking a drug.

Comorbid conditions with higher rates of death and severity are cardiovascular disease, diabetes, high blood pressure, chronic respiratory diseases and cancer.36 Of the five conditions in this list, four are significantly affected by metabolic dysfunction. The common denominator is insulin resistance, which is triggered by a diet of high amounts of carbohydrates and processed foods.

When your body is insulin resistant it is also not metabolically flexible. As Dr. Sandra Weber, president of the American Association of Clinical Endocrinologists, noted:37

“We know that if you do not have good glucose control, you’re at high risk for infection, including viruses and presumably this one [COVID-19] as well … [improving glucose control] would put you in a situation where you would have better immune function.”

What and when you eat has a strong influence on your ability to beat insulin resistance. Intermittent fasting promotes insulin sensitivity and improves blood sugar management. This strategy helps to resolve Type 2 diabetes, high blood pressure, obesity and other conditions affected by metabolic dysfunction. To read more about how intermittent fasting affects insulin sensitivity, see “Intermittent Fasting Instead of Insulin for Type 2 Diabetes.”

Researchers have also found compelling evidence that maintaining optimal levels of vitamin D helps to lower your risk of severe disease. Since scientists anticipate a second wave of illness in the fall, you have a known “deadline” to raise your vitamin D level to at least 60 ng/mL and up to 80 ng/mL by that time.

Importantly, research published April 28, 2020 showed vitamin D insufficiency is prevalent in severe cases of COVID-19.38 They also found 100% of people under age 75 admitted to the intensive care unit had vitamin D insufficiency. For a more in depth discussion of how your vitamin D level will impact your risk and how to optimize your levels see “Your Vitamin D Level Must Reach 60ng/mL Before the Second Wave.”

So, how do you go about optimizing your vitamin D level? First, you need to find out what your base level is, which is done using a simple blood test. An easy and cost-effective way of doing this is to order GrassrootsHealth’s vitamin D testing kit.

Once you know what your blood level is, you can assess the dose needed to maintain or improve your level. Again, the ideal level you’re looking for is above 40 ng/mL, and ideally between 60 ng/mL and 80 ng/mL (European measurement: 100 nmol/L or, ideally, 150 nmol/L to 200 nmol/L).

Next, you can fine-tune your dosage further by taking into account your baseline vitamin D level. To do that, you can either use the chart below, or use GrassrootsHealth’s Vitamin D*calculator. To convert ng/mL into the European measurement (nmol/L), simply multiply the ng/mL measurement by 2.5.

Along with intermittent fasting and optimizing your vitamin D levels, you’ll find a list of more strategies you can simply incorporate into your daily routine at “Want to Defeat Coronavirus? Address Diabetes and Hypertension.”

Original Source:

With all of us restricted to our homes, huge stress triggers about our health form the backdrop of the coronavirus pandemic. How many times do you find yourself worrying anxiously about the what-if scenarios, only to search online for COVID-19 insurance? A quick search online, a few clicks on your favourite digital wallet app and you are all set to face the novel virus just with a few hundred rupees. Phew, easy isn’t it?

The insurance sector is now witnessing a slew of new players joining the fray, selling insurance primarily online, keeping costs and premiums low (including ‘sachetising’ the product) to disrupt the traditional model of buying and servicing the insurer.

Appealing to the digitally-savvy Indian consumer is easier than ever as more Indians take to the internet and offer the largest opportunity globally (apart from the US) for venture capitalists to target Indian customers. And why not, you ask?

InsurtechAlso ReadNikhil Kamath of Zerodha on everything you need to know about investing and trading during COVID-19India is a goldmine for any investor as it has:The second-largest population in the world (second only to China which is closed to outside investments)More than 50 percent of its population is below the age of 25 and more than 65 percent below the age of 35. It is expected that, in 2020, the average age of an Indian will be 29 years.The lowest cost of data globallyThe second-largest smartphone population in the worldRoughly 600 million monthly active customers accessing the world wide webLowest levels of insurance penetration at 3.69 percent.

Consumers are bombarded with product information, how to buy insurance online for their cycle, their mobile phone, even their branded spectacles – all on their devices.

This zealousness of the investor community in India’s fast-emerging disruptor of the large insurance companies (standing at 24 life insurers, 34 general insurers) is reflected in the $183 million that flowed into the ecosystem in 2019. This has lead to the emergence of a new category of fintech called InsurTech.

InsurTech is a combination of the words “insurance” and “technology,” inspired by the term fintech. InsurTech is a term used for a company using technology to disrupt the insurance industry.

India stands at the second position, globally, given PE/VC investments in InsurTech (cecond only to the US). It’s noteworthy, that large technology companies, global digital giants such as Amazon, Google, Alibaba, and Tencent have all entered the InsurTech fray, creating global disruption.

Policybazaar and Bankbazaar have become the go-to destinations for aggregated experiences across search, discovery, and comparison. Customers aren’t, however, looking for life insurance but searching for incident-specific protection – like missing a flight, taking a cab ride on a cab aggregator platform or a hotel stay during a low-cost holiday.

This need is served by micro-insurer startups marking the emergence of an interesting new trend disrupting the traditional model by making insurance available to all and for various micro categories, easier, cheaper and faster.

Some have partnered with large digital giants to scale distribution and use case coverage to innovate on new product categories.

Quoting from a recent piece by Rahul Mathur, Startup Lead at Accenture FinTech Innovation Lab, who writes on this sector, there are three emerging InsurTech “trends” in India —

Embedded insurance – Acko Insurance leads the pack here with its recent partnership with OYO Rooms.Small ticket insurance – Incumbent insurers have caught on fast with this trend, but Toffee Insurance stands out with its Kamai Bachao Yojna, dengue insurance, etc.Novel distribution mechanisms – Bancassurance 2.0, digital channels etc; Max Bupa Health Insurance and IDBI Bank win with the Any Time Health (ATH) machines.

In the post-COVID world, where contact-free becomes the new mantra, face-to-face meetings and operational processes requiring high touch methods are bound to get obsolete.

To deal with the pandemic, we have observed that the speed of policymaking is unprecedented, therefore, it is the right time to identify opportunities of disruption and striking while the iron is hot — the opportunity is here and now.

Also ReadWhy Kunal Shah believes you shouldn’t envy others’ money but their skills insteadOpportunities for insurers post-COVID-19

Here are five opportunities for Incumbents and Disruptors in the post-COVID world to lower the barriers of friction, knowledge, and pricing, for customers to participate in this value chain to protect themselves, their family, business, homes, and other valuable assets

1. Reimagining the core market and productReaching the un(der)insured with the right products and fit

Emerging solutions for new markets and new customers (bite-sized insurance, pay-as-you-use, bundling insurance with Use Cases)

Usage or behaviour-based personalised insurance (one size fits all strategy will not work for the new segment of users, customisation is key)2. Customer Experience Management and Reducing Friction in the product life cycle New players have been able to instantly stand-up all insurance-related processes to provide a digital experience to consumers. Taking a leaf from their book, creating a digital-first, mobile-only experience is key to winning new users.

Friction in disjointed experiences and ease of finding information has been sighted as the major reasons why consumers opt for searching for insurance products with new-age players instead of traditional insurers. Usher in innovative ways to settle claims, and catching fraudulent users while safeguarding the experience of good trustworthy individuals.

Online payments are observed even in hinterland even though India is a cash-based economy. Focus and prioritise safety, security and, convenience in payment methods to appeal to all consumers in buying insurance, paying premiums, receiving settlements, etc.3. Leverage New-Age Tech to Bolster GrowthWith the emergence of blockchain, AI, and other technologies, integrate them into now to reap the dividends later.

Sharper Underwriting to bring more people into insurance covers. Reinvent this area use of data, analytics, and Machine Learning.

Robotic Process Automation (RPA) for the automation of business activities and processes.

Using technology to aid fraud detection at the point of underwriting, assessing risk, and weeding out gamers from the ecosystem.

Robo Advisory to help users pick the right insurance products.4. Digital First (Selling and Servicing)Move away from the brick-and-mortar model of selling insurance covers, servicing clients.

Overuse 3V’s: voice, video and vernacular to over-communicate why insurance is a priority for everyone in the post-COVID era, and how to stay invested in the long term.

Drive retention and renewals with aggressive digital selling and service.

Create a social revolution: Moving education online and educating users digitally.

Rethink Human Capital Strategies: Upskilling sales and agents is key to ensuring customers do not opt for competitors who have highly qualified staff to address queries and concerns emerging from the lack of face-to-face interaction involved in the sell and the retain stages of the customer life cycle.5. Addressing Cyber Security as an Emerging Category while protecting consumer dataInvest in data privacy for customers, employees, and the business. Data breaches cost the business; brand risk is only a small casualty when compared to the cost of acquiring servicing a customer over the lifetime of the product.

Digitisation brings huge responsibility of being able to protect customer and business-sensitive data from malicious hackers.

Addressing Cyber Security Insurance as a product category: The risk of escalating cyber threats have created a completely new need for businesses to safeguard themselves with risk mitigation solutions against data breaches and cyber-attacks. Cyber insurance market is expected to grow to $9 billion by 2020. Startups in cyber insurance are enablers of ‘CISO-as-a-service’ for SMBs. This is a big opportunity as the threat of cyber attacks increases

Also ReadCoronavirus: Adapting business during COVID-19 pandemic


Whenever customer friction intersects with untapped profit potential, disruption is bound to occur. The Indian insurance sector is at the cusp of exponential growth.

For insurers to participate and contribute to this growth, it is imperative that they are not only aware of emerging trends, but also that they embrace these trends holistically.

Embracing digital transformation forged by quick decisions and investment into the business is the key to future growth and sustenance.

(Edited by Kanishk Singh)

(Disclaimer: The views and opinions expressed in this article are those of the author and do not necessarily reflect the views of YourStory.)

How has the coronavirus outbreak disrupted your life? And how are you dealing with it? Write to us or send us a video with subject line 'Coronavirus Disruption' to [email protected]

Original Source:

Kolkata boys Rajit Bhattacharya (23) and Ankit Das (22) met as toddlers at nursery school. The two friends grew up together, attending the city’s well-known South Point School. They also landed up at the same engineering college, Jadavpur University. There they met Aisik Paul (23), who was pursuing electronics and telecommunications engineering with Rajit, while Ankit studied chemical engineering. 

The three friends often worked together for various college events and festivals. The trio was adamant about “starting something of their own” and not taking up jobs after graduating from engineering college. That’s why they chose not to appear for a single interview during college placements.

data sutram

Data Sutram co-founders Ankit Das, Aisik Paul and Rajit Bhattacharya (L-R)

In 2018, their final year of college, the batch mates set up data startup Data Sutram, after having skipped placements and amid stiff resistance from their families. 

“Jadavpur University, ranked among the top engineering colleges in India, is known for its placement record and job offers. Coming from service backgrounds, we had immense resistance from our families for not sitting for placements,” say Aisik and Ankit. 

Both their fathers had government jobs. While Aisik’s father was a deputy chief engineer at the state-run Damodar Valley Corporation (DVC), Ankit’s father was a senior civil engineer working for the government of West Bengal.

The resistance from Rajit’s folks was relatively less as his parents had an entrepreneurial background. The senior Bhattacharya, an IIT-graduate, was an engineer in a US firm, before he set up a social enterprise two decades back with Rajit’s mother, also a Jadavpur University engineering graduate. 

Besides the placements, there was also pressure from the families on the three young men to pursue MBA. The group jokes that till date Ankit's father sends him MBA preparation material.

“I think one of the fundamental reasons we didn't pursue MBA is summarised by simple data that suggests that the conversion of MBA graduates into entrepreneurs right after MBA is very low, not just in India but internationally.

“I feel what drew us to entrepreneurship was our technology's ability to make a difference to solve problems. I feel we had really good mentors who helped us bridge the business gap, to never really feel like we needed it, (an MBA)” Rajit says.

The startup was inspired by two major events that led the trio to discover “the power of unstructured data”. 

The first was an internship project in their third year, where they developed a platform that used satellite data to predict crop yield and help the government plan fertiliser distribution and subsidies across the state to encourage farmers to grow and meet demand. 

The second was when they developed a predictive analytics solution for a retail chain as part of a project that measured demographic and ethnic distributions around a store to estimate the potential sales of each grocery item. 

Also ReadMeet the Mumbai boy from Silicon Valley who wants to help India fight coronavirus
What does Data Sutram do?

The Kolkata startup helps businesses increase delivery efficiency and reduce marketing burn. “With our data and insight, companies have increased deliveries by over 35 percent, increased growth of push channel by up to 20 percent, and reduced marketing burn by 60 percent,” Rajit says.

With a global shift in focus from globalisation to localisation and the boom of ecommerce, the need of the hour is hyper-local data and actionable insights, he explains. 

Data Sutram uses Artificial Intelligence (AI) methodologies such as Optical Character Recognition (OCR) and Natural Language Processing (NLP) to uncover these raw data sources and compute socio-economic parameters like demography, ethnicity, affluence, and spending capacity to understand a location and help a business. 

This is done by pinpointing new locations for business to expand, improving performance of existing assets (both physical and digital), and microtargeting the right audience for the product. 

According to market research and consulting firm Mordor Intelligence, the data as a service (DaaS) market was valued at $26.23 billion in 2019 and is expected to reach $46.50 billion by 2025, at a compound annual growth rate of 10 percent over the forecast period of 2020-2025.

Data Sutaram expects to break even in three years and hit the Rs 1 crore revenue mark within a year.

Also ReadMeet the Swedish wine expert who fell in love with India and made it her home
What’s under the hood?

The Data Sutram platform comprises two parts: a data engine and a visualisation platform. The first part is an AI engine that automatically processes raw data from multiple sources, cleans, geotags, structures, and marries it to create socio-economic demographic indexes about every location at various granularity levels. 

“The data engines tap into over 178 data sources of both public and private, including satellites,” Rajit says. 

The visualisation platform is a Geographic Information System (GIS) platform that integrates data visualisation and data analytics to help clients visualise the impact of their decisions on the locations and give them insight to help them leverage the power of location data. 

“The unstructured data lying in the form of text and images within multiple sources is like raw cotton that needs to be processed, cleaned, geotagged and converted into textile that can be readily utilised by a business,” Rajit explains.

As far as competition in India is concerned, it includes the likes of Bengaluru-based location intelligence startups and GeoIq. 

However, Data Sutram believes its “ability to make use of unstructured data (in the form of images, text in different languages not readily consumable for a business) through its AI engine” sets it apart.

Also ReadMeet Jamie Alter, the white man with an Indian passport and heart
Investment pitches and funding 

The startup was initially bootstrapped and surviving on revenue from consultancy projects, with six engineers on board. Three months after graduating from engineering college, the trio received a call from serial entrepreneur-turned-angel investor Sanjay Mehta to come pitch in Mumbai to be part of the first cohort of 100X.VC, a venture capital firm set up by him.

The team managed to raise its first cheque within two days of its maiden investment pitch. 

“Two weeks of the 100X.VC programme gave exposure to a huge industry circuit and funding circle opened up a lot of opportunities for us fresh-out-of-college engineers and proved to be a life-changing event,” Rajit says.

Data Sutaram raised Rs 25 lakh from 100X.VC. It is currently in talks with angel networks to raise around Rs 2 crore within the next two-three months. 

Currently the startup has a 11-member team, including the three co-founders.

Also ReadCoronavirus crisis: This tiny, inexpensive device may be able to save thousands of lives
Coronavirus disruption and improvisation

Data Sutram’s focus sectors are retail, ecommerce, agri tech and BFSI (Banking, Financial Services and Insurance). Amid the coronavirus pandemic, the retail sector has taken a big hit and the startup’s clients have been unable to pay for the services. 

“However, with a quick turnaround time, our focus has shifted towards essential services like groceries and pharmacies,” Rajit says.

Just as location intelligence methodologies such as geofencing and geo-targeting are being utilised by the government to tackle the spread of the coronavirus, the same can be done to solve the bottlenecks that have come up in supply-chain logistics, he adds.

“Our platform along with the population density, store coordinates, and other external data points can predict the demand of essential commodities for every locality. The platform can track the demand real time and prevent an area from having a shortage crisis by alerting distributors, pharma and grocery chains, and authorities about an impending crisis.”

Citizens can also alert and convey their need for essential goods that they are unable to find in their neighbourhood by directly accessing the platform and submitting their query. 

“Our platform has helped one of the most reputed pharma brands of western India to deliver medicines to a larger number of housing societies in Mumbai, Pune and Thane, helping it utilise its resources more efficiently,” Rajit says. 

(Edited by Teja Lele Desai)

How has the coronavirus outbreak disrupted your life? And how are you dealing with it? Write to us or send us a video with subject line 'Coronavirus Disruption' to [email protected]

Original Source:

Bill Gates — who illegally invests in the same industries he gives charitable donations to, and who promotes a global public health agenda that benefits the companies he’s invested in — has gone on record saying life will not go back to normal until we have the ability to vaccinate the entire global population against COVID-19.1

To that end, he is pushing for disease surveillance and a vaccine tracking system2 that might involve embedding vaccination records on our bodies. One example of how this might be done is using an invisible ink quantum dot tattoo, described in a December 18, 2019, Science Translational Medicine paper.3,4

According to statements made by Gates, societal and financial normalcy may never return to those who refuse vaccination, as the digital vaccination certificate Gates is pushing for might ultimately be required to go about your day-to-day life and business. Without this “digital immunity proof,” you may not even be allowed to travel locally or visit certain public buildings.

Gates has a history of “predicting” global pandemics with vast numbers of deaths,5 and with his call for a tracking system to keep tabs on infected/noninfected and vaccinated/unvaccinated individuals, he’s ensuring an unimaginably profitable future for the vaccine makers he supports and makes money from via his Foundation investments.

Along with Gates, The Rockefeller Foundation is also coordinating efforts in the direction of social control through the implementation of draconian COVID-19 tracking and tracing measures that are clearly meant to become permanent.

National COVID-19 Testing Action Plan

April 21, 2020, The Rockefeller Foundation released a white paper6 titled, “National COVID-19 Testing Action Plan — Strategic Steps to Reopen Our Workplaces and Our Communities.” In the foreword, Rockefeller Foundation president Dr. Rajiv J. Shah writes:

“In the face of an ineffective nationally-coordinated response, insufficient data, and inadequate amounts of protective gear and testing, we need an exit plan. Testing is our way out of this crisis.

Instead of ricocheting between an unsustainable shutdown and a dangerous, uncertain return to normalcy, the United States must mount a sustainable strategy with better tests and contact tracing, and stay the course for as long as it takes to develop a vaccine or cure.

Any plan to do so must win the faith of private and public sector leaders across the country, and of individual Americans that they and their loved ones will be safer when we begin to return to daily life.

The Rockefeller Foundation exists to meet moments like this. In the past two weeks we have brought together experts and leaders from science, industry, academia, public policy, and government — across sectors and political ideologies — to create a clear, pragmatic, data-driven, actionable plan to beat back Covid-19 and get Americans back to work more safely.”

The plan calls for testing and tracing 1 million Americans per week to start, incrementally ramping it up to 3 million and then 30 million per week (the “1-3-30 plan”) over the next six months until the entire population has been covered.

Test results would then be collected on a digital platform capable of tracking all tested individuals so that contact-tracing can be performed when someone tests positive. According to the “National COVID-19 Testing Action Plan”:

“Policy makers and the public must find the balance between privacy concerns and infection control to allow the infection status of most Americans to be accessed and validated in a few required settings and many voluntary ones.”

To this end, they suggest using incentives “to nudge the voluntary use” of tracking and contact tracing apps rather than making them mandatory. They also call for the use of “innovative digital technologies” aimed at improving “workforce monitoring and early detection of recurrent outbreaks.”

“When integrated into national and state surveillance systems, such innovations may enable the same level of outbreak detection with fewer tests.

Promising techniques include anonymous digital tracking of workforces or population-based resting heart-rate and smart thermometer trends; continually updated epidemiological data modeling; and artificial intelligence projections based on clinical and imaging data,” the document states.7

Modern ‘Wartime’ Effort That Will Cost Billions

According to the “National COVID-19 Testing Action Plan”:8

“Monitoring the pandemic and adjusting social distancing measures will require launching the largest public health testing program in American history … The effort will ultimately grow to billions of dollars per month … But with widespread business closures costing the country $350 billion to $400 billion each month, the expense will be worth it.

This testing infrastructure is intended to tide the country over until a vaccine or therapy is widely available.

Coordination of such a massive program should be treated as a wartime effort, with a public/private bipartisan Pandemic Testing Board established to assist and serve as a bridge between local, state, and federal officials with the logistical, investment and political challenges this operation will inevitably face.”

Don’t Be Naïve About Infectious Tracking Plan

Call me jaded, but this sounds like a plan to surveil Americans so that they can easily be tracked down for mandatory vaccination once a COVID-19 vaccine becomes available. It also creates the necessary infrastructure for vaccination tracking across the board, for all vaccines.

While they give lip-service to privacy and anonymization of data, privacy promises have been repeatedly broken in the past. Besides, the document clearly states that:9

“Some privacy concerns must be set aside for an infectious agent as virulent as Covid-19, allowing the infection status of most Americans to be accessed and validated in a few required settings and many voluntary ones.

The loss of privacy engendered by such a system would come at too high of a price if the arrival of a vaccine early next year was a certainty. But vaccine development and manufacture could take years, and when it comes certain populations may be excluded from receiving it for health reasons.

In the meantime, infection status must be known for people to participate in many societal functions. Legislation protecting people from being fired over infection status must be passed.

Those screened must be given a unique patient identification number that would link to information about a patient’s viral, antibody and eventually vaccine status under a system that could easily handshake with other systems to speed the return of normal societal functions.

Schools could link this to attendance lists, large office buildings to employee ID cards, TSA to passenger lists and concert and sports venues to ticket purchasers. Such connections should be made in a way that protects personally identifying information whenever possible … Whenever and wherever possible data should be open.”

patient identification number
Are You Ready to Give Up EVERYTHING Over a Virus?

“Privacy concerns must be set aside.” Infection status must be “accessed and validated in a few required settings.”

Infection status will be linked to schools, office buildings, places of work, airports, concert and sport venues — in other words, most areas people need or want to frequent, if not daily, then at least occasionally. Infection status must be known “for people to participate in societal functions.” Legislation must be passed to protect people from being fired from their jobs based on their infection status. Are you concerned yet?

Anyone who remembers the tactics employed in Nazi Germany, or anyone familiar with the current surveillance of the Chinese population, will realize where this is headed.

Reading through the plan, it should also be crystal clear that this tracking and surveillance program is not designed to be temporary. You can be strongly assured this will be permanent. It calls for hundreds of thousands of new employees, updating computer systems and new laws that in many ways resemble the implementation of TSA post-9/11.

Not addressed in this report is the question of just how often would you have to undergo testing. A negative test today may not be valid tomorrow, if you happen to come across someone who is infected between now and then. Would you have to undergo testing every single day? Once a week?

If regular retesting is not part of the plan, then the whole system is worthless as your infection status could change at any time.

Other questions not addressed: If you happen to be in the vicinity of someone who tests positive in the near future, would you have to quarantine for two weeks? Will your employer pay for that time off? Will you have a job when you come out of quarantine?

What if you quarantine for two weeks but don’t get sick and test negative for antibodies, then go out and happen across yet another person who ends up testing positive shortly thereafter. Will you be forced into quarantine again? Where does it end?

The tracking system The Rockefeller Foundation is calling for is eerily similar to that already being used in China, where residents are required to enroll in a health condition registry. Once enrolled, they get a personal QR code, which they must then enter in order to gain access to grocery stores and other facilities.10

The plan also demands access to other medical data. According to the “National COVID-19 Testing Action Plan”:11

“This infection database must easily interoperate with doctor, hospital and insurance health records in an essential and urgent national program to finally rationalize the disparate and sometimes deliberately isolated electronic medical records systems across the country …

Unfortunately, obtaining the necessary clinical data to bring these powerful analytic tools to bear has been difficult due to information-blocking tactics of electronic health records (EHR) vendors. Among the longtime tactics used by such vendors has been charging unreasonable fees for data access, requiring providers to sign restrictive contracts, and claiming patients’ clinical data is proprietary.

On March 9, the Department of Health and Human Services (HHS) released two long-awaited final rules that would prohibit information blocking in health care and advance more seamless exchange of health care data. But publication in the Federal Register, necessary to activate the rules, has been inexplicably delayed. This delay must end.”

In other words, this plan is far more comprehensive than merely tracking COVID-19 cases. It’s designed to replace the current system of “disparate and sometimes deliberately isolated electronic medical records systems across the country.”


While The Rockefeller Foundation’s white paper simply calls for the use of a digital “patient identification number” without indicating exactly how you would carry this ID number on your person, Gates has repeatedly talked about the “need” for some sort of implantable vaccine certificate.

In 1999, The Bill & Melinda Gates Foundation donated $750 million to set up Gavi, The Vaccine Alliance.12 Gavi, in turn, has partnered with the ID2020 Alliance, along with the Bangladeshi government, to launch a digital identity program called ID2020.13

The Bill & Melinda Gates Foundation also funded the GSMA Inclusive Tech Lab, launched in 2019, the aim of which is to promote access to digital and biometric identity services and systems.14,15

ID2020, which also launched in 2019, is designed to “leverage immunization as an opportunity to establish digital identity.” This digital identity system is said to carry “far-reaching implications for individuals’ access to services and livelihoods,” so to think that Gates’ call for implantable COVID-19 vaccine certificates would be limited to that alone would again be a grave mistake.

Like The Rockefeller Foundation, Gates is not presenting short-term, temporary measures. They’re both aiming to implement a totalitarian control system. It’s not so far-fetched to imagine a future in which your vaccine certificate or “unique patient ID number” replaces personal identifications such as your driver’s license, state ID card, Social Security card and passport, and is tied not only to your medical records in total, but also your finances.

I remain confident that it would be a tragic mistake to trust Gates, Rockefeller, Google or any of the other players that are being brought before us as the saviors of the day. While most people are well-acquainted with the Rockefeller name, few probably know the true history of the Rockefellers’ rise to power. If you fall in this category, be sure to read “How the Oil Industry Conquered Medicine, Finance and Agriculture,” which features an excellent video report by James Corbett.

Those who are ignorant of history are bound to repeat it, and if the Rockefeller story tells us anything, it is that unless we realize what has been done, we’ll be deceived again and again, because the oil oligarchy’s end game is yet to be realized — if we let them.

Original Source:

Visit Us On TwitterVisit Us On FacebookVisit Us On YoutubeVisit Us On Instagram